The role and mechanism of protein post‑translational modification in vascular calcification (Review)
- Authors:
- Dongyan Wang
- Qin Li
- Caidie Xie
-
Affiliations: Department of Medical Science, Yangzhou Polytechnic College, Yangzhou, Jiangsu 225100, P.R. China, Department of Nephrology, Nanjing Second Hospital, Nanjing Hospital Affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210037, P.R. China - Published online on: September 6, 2024 https://doi.org/10.3892/etm.2024.12708
- Article Number: 419
-
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
|
Li J, Li C, Huang Z, Huang C, Liu J, Wu T, Xu S, Mai P, Geng D, Zhou S, et al: Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells. Front Pharmacol. 14(1295463)2023.PubMed/NCBI View Article : Google Scholar | |
|
Urbain F, Ponnaiah M, Ichou F, Lhomme M, Materne C, Galier S, Haroche J, Frisdal E, Mathian A, Durand H, et al: Impaired metabolism predicts coronary artery calcification in women with systemic lupus erythematosus. EBioMedicine. 96(104802)2023.PubMed/NCBI View Article : Google Scholar | |
|
Zhang H, Li G, Yu X, Yang J, Jiang A, Cheng H, Fu J, Liang X, Liu J, Lou J, et al: Progression of vascular calcification and clinical outcomes in patients receiving maintenance dialysis. JAMA Netw Open. 6(e2310909)2023.PubMed/NCBI View Article : Google Scholar | |
|
Snell-Bergeon JK, Budoff MJ and Hokanson JE: Vascular calcification in diabetes: Mechanisms and implications. Curr Diab Rep. 13:391–402. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Alman AC, Maahs DM, Rewers MJ and Snell-Bergeon JK: Ideal cardiovascular health and the prevalence and progression of coronary artery calcification in adults with and without type 1 diabetes. Diabetes Care. 37:521–528. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Berry C, Tardif JC and Bourassa MG: Coronary heart disease in patients with diabetes: Part I: Recent advances in prevention and noninvasive management. J Am Coll Cardiol. 49:631–642. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Yahagi K, Kolodgie FD, Lutter C, Mori H, Romero ME, Finn AV and Virmani R: Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler Thromb Vasc Biol. 37:191–204. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Doherty TM, Fitzpatrick LA, Inoue D, Qiao JH, Fishbein MC, Detrano RC, Shah PK and Rajavashisth TB: Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev. 25:629–672. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD and Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American heart association. Circulation. 92:1355–1374. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:801–809. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Sharif N, Gilani SZ, Suter D, Reid S, Szulc P, Kimelman D, Monchka BA, Jozani MJ, Hodgson JM, Sim M, et al: Machine learning for abdominal aortic calcification assessment from bone density machine-derived lateral spine images. EBioMedicine. 94(104676)2023.PubMed/NCBI View Article : Google Scholar | |
|
Wang M, Niu G, Chen Y, Zhou Z, Feng D, Zhang Y and Wu Y: China-DVD2 Study Group (Standard Evaluation and Optimal Treatment for Elderly Patients with Valvular Heart Disease, National Key R&D Program of China, NCT05044338):. Development and validation of a deep learning-based fully automated algorithm for pre-TAVR CT assessment of the aortic valvular complex and detection of anatomical risk factors: A retrospective, multicentre study. EBioMedicine. 96(104794)2023.PubMed/NCBI View Article : Google Scholar | |
|
Park S, Choi ES, Jung HW, Lee JY, Park JW, Bang JS and Jeon YT: Preoperative serum alkaline phosphatase and neurological outcome of cerebrovascular surgery. J Clin Med. 11(2981)2022.PubMed/NCBI View Article : Google Scholar | |
|
Bardeesi ASA, Gao J, Zhang K, Yu S, Wei M, Liu P and Huang H: A novel role of cellular interactions in vascular calcification. J Transl Med. 15(95)2017.PubMed/NCBI View Article : Google Scholar | |
|
Durham AL, Speer MY, Scatena M, Giachelli CM and Shanahan CM: Role of smooth muscle cells in vascular calcification: Implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 114:590–600. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Niu Z, Su G, Li T, Yu H, Shen Y, Zhang D and Liu X: Vascular calcification: New insights into BMP type I receptor A. Front Pharmacol. 13(887253)2022.PubMed/NCBI View Article : Google Scholar | |
|
Pan X, Pi C, Ruan X, Zheng H, Zhang D and Liu X: Mammalian sirtuins and their relevance in vascular calcification. Front Pharmacol. 13(907835)2022.PubMed/NCBI View Article : Google Scholar | |
|
Feng S, Qi Y, Xiao Z, Chen H, Liu S, Luo H, Wu H and Zhang W: CircHIPK3 relieves vascular calcification via mediating SIRT1/PGC-1α/MFN2 pathway by interacting with FUS. BMC Cardiovasc Disord. 23(583)2023.PubMed/NCBI View Article : Google Scholar | |
|
Song GY, Guo XN, Yao J, Lu ZN, Xie JH, Wu F, He J, Fu ZL and Han J: Differential expression profiles and functional analysis of long non-coding RNAs in calcific aortic valve disease. BMC Cardiovasc Disord. 23(326)2023.PubMed/NCBI View Article : Google Scholar | |
|
Wu M, Rementer C and Giachelli CM: Vascular calcification: An update on mechanisms and challenges in treatment. Calcif Tissue Int. 93:365–373. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Demer LL and Tintut Y: Vascular calcification: Pathobiology of a multifaceted disease. Circulation. 117:2938–2948. 2008.PubMed/NCBI View Article : Google Scholar | |
|
McCullough PA, Chinnaiyan KM, Agrawal V, Danielewicz E and Abela GS: Amplification of atherosclerotic calcification and Mönckeberg's sclerosis: A spectrum of the same disease process. Adv Chronic Kidney Dis. 15:396–412. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Beltrao P, Bork P, Krogan NJ and van Noort V: Evolution and functional cross-talk of protein post-translational modifications. Mol Syst Biol. 9(714)2013.PubMed/NCBI View Article : Google Scholar | |
|
Wang R and Wang G: Protein modification and autophagy activation. Adv Exp Med Biol. 1206:237–259. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Liu Y and Peng FX: Research progress on O-GlcNAcylation in the occurrence, development, and treatment of colorectal cancer. World J Gastrointest Surg. 13:96–115. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Mir AR and Moinuddin : Glycoxidation of histone proteins in autoimmune disorders. Clin Chim Acta. 450:25–30. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Tweedie-Cullen RY, Reck JM and Mansuy IM: Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain. J Proteome Res. 8:4966–4982. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Voelkl J, Lang F, Eckardt KU, Amann K, Kuro-O M, Pasch A, Pieske B and Alesutan I: Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Cell Mol Life Sci. 76:2077–2091. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Lee HY, Lim S and Park S: Role of inflammation in arterial calcification. Korean Circ J. 51:114–125. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Neutel CHG, Hendrickx JO, Martinet W, De Meyer GRY and Guns PJ: The protective effects of the autophagic and lysosomal machinery in vascular and valvular calcification: A systematic review. Int J Mol Sci. 21(8933)2020.PubMed/NCBI View Article : Google Scholar | |
|
Kwon DH, Ryu J, Kim YK and Kook H: Roles of histone acetylation modifiers and other epigenetic regulators in vascular calcification. Int J Mol Sci. 21(3246)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM and Wang EA: Novel regulators of bone formation: Molecular clones and activities. Science. 242:1528–1534. 1988.PubMed/NCBI View Article : Google Scholar | |
|
Cai J, Pardali E, Sánchez-Duffhues G and ten Dijke P: BMP signaling in vascular diseases. FEBS Lett. 586:1993–2002. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Rong S, Zhao X, Jin X, Zhang Z, Chen L, Zhu Y and Yuan W: Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt/β-catenin pathway. Cell Physiol Biochem. 34:2049–2060. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Balderman JA, Lee HY, Mahoney CE, Handy DE, White K, Annis S, Lebeche D, Hajjar RJ, Loscalzo J and Leopold JA: Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. J Am Heart Assoc. 1(e003905)2012.PubMed/NCBI View Article : Google Scholar | |
|
Derwall M, Malhotra R, Lai CS, Beppu Y, Aikawa E, Seehra JS, Zapol WM, Bloch KD and Yu PB: Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol. 32:613–622. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Nakagawa Y, Ikeda K, Akakabe Y, Koide M, Uraoka M, Yutaka KT, Kurimoto-Nakano R, Takahashi T, Matoba S, Yamada H, et al: Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo. Arterioscler Thromb Vasc Biol. 30:1908–1915. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Graciolli FG, Neves KR, dos Reis LM, Graciolli RG, Noronha IL, Moysés RM and Jorgetti V: Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia. Nephrol Dial Transplant. 24:1416–1421. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, McDonald JM and Chen Y: Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 283:15319–15327. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Lin ME, Chen T, Leaf EM, Speer MY and Giachelli CM: Runx2 expression in smooth muscle cells is required for arterial medial calcification in mice. Am J Pathol. 185:1958–1969. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Sun Y, Byon CH, Yuan K, Chen J, Mao X, Heath JM, Javed A, Zhang K, Anderson PG and Chen Y: Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ Res. 111:543–552. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et al: Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 89:309–319. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, et al: Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12:1260–1268. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Morony S, Tintut Y, Zhang Z, Cattley RC, Van G, Dwyer D, Stolina M, Kostenuik PJ and Demer LL: Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation. 117:411–420. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Tschiderer L, Willeit J, Schett G, Kiechl S and Willeit P: Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26, 442 participants. PLoS One. 12(e0183910)2017.PubMed/NCBI View Article : Google Scholar | |
|
Morena M, Jaussent I, Halkovich A, Dupuy AM, Bargnoux AS, Chenine L, Leray-Moragues H, Klouche K, Vernhet H, Canaud B and Cristol JP: Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients. PLoS One. 7(e36175)2012.PubMed/NCBI View Article : Google Scholar | |
|
Valdivielso JM: Vascular calcification: Types and mechanisms. Nefrologia. 31:142–147. 2011.PubMed/NCBI View Article : Google Scholar : (In Spanish). | |
|
Fitzpatrick LA, Severson A, Edwards WD and Ingram RT: Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest. 94:1597–1604. 1994.PubMed/NCBI View Article : Google Scholar | |
|
Speer MY, McKee MD, Guldberg RE, Liaw L, Yang HY, Tung E, Karsenty G and Giachelli CM: Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med. 196:1047–1055. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Johnson ML and Rajamannan N: Diseases of Wnt signaling. Rev Endocr Metab Disord. 7:41–49. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Heath JM, Sun Y, Yuan K, Bradley WE, Litovsky S, Dell'Italia LJ, Chatham JC, Wu H and Chen Y: Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus. Circ Res. 114:1094–1102. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Deng L, Huang L, Sun Y, Heath JM, Wu H and Chen Y: Inhibition of FOXO1/3 promotes vascular calcification. Arterioscler Thromb Vasc Biol. 35:175–183. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM and Weissberg PL: Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 87:1055–1062. 2000.PubMed/NCBI View Article : Google Scholar | |
|
New SEP and Aikawa E: Role of extracellular vesicles in de novo mineralization: An additional novel mechanism of cardiovascular calcification. Arterioscler Thromb Vasc Biol. 33:1753–1758. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Coscas R, Bensussan M, Jacob MP, Louedec L, Massy Z, Sadoine J, Daudon M, Chaussain C, Bazin D and Michel JB: Free DNA precipitates calcium phosphate apatite crystals in the arterial wall in vivo. Atherosclerosis. 259:60–67. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Li M, Wang ZW, Fang LJ, Cheng SQ, Wang X and Liu NF: Programmed cell death in atherosclerosis and vascular calcification. Cell Death Dis. 13(467)2022.PubMed/NCBI View Article : Google Scholar | |
|
Chen Y, Wei L, Zhang X, Liu X, Chen Y, Zhang S, Zhou L, Li Q, Pan Q, Zhao S and Liu H: 3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5. Oncol Rep. 40:2435–2444. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Chiong M, Cartes-Saavedra B, Norambuena-Soto I, Mondaca-Ruff D, Morales PE, García-Miguel M and Mellado R: Mitochondrial metabolism and the control of vascular smooth muscle cell proliferation. Front Cell Dev Biol. 2(72)2014.PubMed/NCBI View Article : Google Scholar | |
|
Chen WR, Zhou YJ, Yang JQ, Liu F, Wu XP and Sha Y: Melatonin attenuates calcium deposition from vascular smooth muscle cells by activating mitochondrial fusion and mitophagy via an AMPK/OPA1 signaling pathway. Oxid Med Cell Longev. 2020(5298483)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen WR, Zhou YJ, Sha Y, Wu XP, Yang JQ and Liu F: Melatonin attenuates vascular calcification by inhibiting mitochondria fission via an AMPK/Drp1 signalling pathway. J Cell Mol Med. 24:6043–6054. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Scheffner M, Nuber U and Huibregtse JM: Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature. 373:81–83. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Kaoutari AE, Fraunhoffer NA, Audebert S, Camoin L, Berthois Y, Gayet O, Roques J, Bigonnet M, Bongrain C, Ciccolini J, et al: Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers. EBioMedicine. 92(104634)2023.PubMed/NCBI View Article : Google Scholar | |
|
Frezza M, Schmitt S and Dou QP: Targeting the ubiquitin-proteasome pathway: An emerging concept in cancer therapy. Curr Top Med Chem. 11:2888–2905. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Xu Q, Pan G, Wang Z, Wang L, Tang Y, Dong J and Qin JJ: Platycodin-D exerts its anti-cancer effect by promoting c-Myc protein ubiquitination and degradation in gastric cancer. Front Pharmacol. 14(1138658)2023.PubMed/NCBI View Article : Google Scholar | |
|
Zhao M, Qiao M, Oyajobi BO, Mundy GR and Chen D: E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem. 278:27939–27944. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Jiang Y, Zhang J, Li Z and Jia G: Bone marrow mesenchymal stem cell-derived exosomal miR-25 regulates the ubiquitination and degradation of Runx2 by SMURF1 to promote fracture healing in mice. Front Med (Lausanne). 7(577578)2020.PubMed/NCBI View Article : Google Scholar | |
|
Choi YH, Kim YJ, Jeong HM, Jin YH, Yeo CY and Lee KY: Akt enhances Runx2 protein stability by regulating Smurf2 function during osteoblast differentiation. FEBS J. 281:3656–3666. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Ouyang L, Yu C, Xie Z, Su X, Xu Z, Song P, Li J, Huang H, Ding Y and Zou MH: Indoleamine 2,3-dioxygenase 1 deletion-mediated kynurenine insufficiency in vascular smooth muscle cells exacerbates arterial calcification. Circulation. 145:1784–1798. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Kim BG, Lee JH, Yasuda J, Ryoo HM and Cho JY: Phospho-Smad1 modulation by nedd4 E3 ligase in BMP/TGF-β signaling. J Bone Miner Res. 26:1411–1424. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Kwon DH, Eom GH, Ko JH, Shin S, Joung H, Choe N, Nam YS, Min HK, Kook T, Yoon S, et al: MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification. Nat Commun. 7(10492)2016.PubMed/NCBI View Article : Google Scholar | |
|
Weng X, Luo X, Dai X, Lv Y, Zhang S, Bai X, Bao X, Wang Y, Zhao C, Zeng M, et al: Apigenin inhibits macrophage pyroptosis through regulation of oxidative stress and the NF-κB pathway and ameliorates atherosclerosis. Phytother Res. 37:5300–5314. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Al-Huseini I, Ashida N and Kimura T: Deletion of IκB-kinase β in smooth muscle cells induces vascular calcification through β-catenin-runt-related transcription factor 2 signaling. J Am Heart Assoc. 7(e007405)2018.PubMed/NCBI View Article : Google Scholar | |
|
Ishiwata R and Morimoto Y: Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification. Biochim Biophys Acta Mol Basis Dis. 1868(166323)2022.PubMed/NCBI View Article : Google Scholar | |
|
Weinert BT, Iesmantavicius V, Moustafa T, Schölz C, Wagner SA, Magnes C, Zechner R and Choudhary C: Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae. Mol Syst Biol. 10(716)2014.PubMed/NCBI View Article : Google Scholar | |
|
Lin R, Tao R, Gao X, Li T, Zhou X, Guan KL, Xiong Y and Lei QY: Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol Cell. 51:506–518. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Gu J, Lu Y, Deng M, Qiu M, Tian Y, Ji Y, Zong P, Shao Y, Zheng R, Zhou B, et al: Inhibition of acetylation of histones 3 and 4 attenuates aortic valve calcification. Exp Mol Med. 51:1–14. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Li SJ, Kao YH, Chung CC, Chen WY, Cheng WL and Chen YJ: Activated p300 acetyltransferase activity modulates aortic valvular calcification with osteogenic transdifferentiation and downregulation of Klotho. Int J Cardiol. 232:271–279. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Bouras T, Fu M, Sauve AA, Wang F, Quong AA, Perkins ND, Hay RT, Gu W and Pestell RG: SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem. 280:10264–10276. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Hecht A, Vleminckx K, Stemmler MP, van Roy F and Kemler R: The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J. 19:1839–1850. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Jeon EJ, Lee KY, Choi NS, Lee MH, Kim HN, Jin YH, Ryoo HM, Choi JY, Yoshida M, Nishino N, et al: Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem. 281:16502–16511. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Jun JH, Yoon WJ, Seo SB, Woo KM, Kim GS, Ryoo HM and Baek JH: BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity. J Biol Chem. 285:36410–36419. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Z, Deepak V, Meng L, Wang L, Li Y, Jiang Q, Zeng X and Liu W: Analysis of HDAC1-mediated regulation of Runx2-induced osteopontin gene expression in C3h10t1/2 cells. Biotechnol Lett. 34:197–203. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Bae HS, Yoon WJ, Cho YD, Islam R, Shin HR, Kim BS, Lim JM, Seo MS, Cho SA, Choi KY, et al: An HDAC inhibitor, entinostat/MS-275, partially prevents delayed cranial suture closure in heterozygous Runx2 null mice. J Bone Miner Res. 32:951–961. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Bartoli-Leonard F, Wilkinson FL, Langford-Smith AWW, Alexander MY and Weston R: The interplay of SIRT1 and Wnt signaling in vascular calcification. Front Cardiovasc Med. 5(183)2018.PubMed/NCBI View Article : Google Scholar | |
|
Takemura A, Iijima K, Ota H, Son BK, Ito Y, Ogawa S, Eto M, Akishita M and Ouchi Y: Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 31:2054–2062. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Lévy L, Wei Y, Labalette C, Wu Y, Renard CA, Buendia MA and Neuveut C: Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol Cell Biol. 24:3404–3414. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Bartoli-Leonard F, Wilkinson FL, Schiro A, Inglott FS, Alexander MY and Weston R: Suppression of SIRT1 in diabetic conditions induces osteogenic differentiation of human vascular smooth muscle cells via RUNX2 signalling. Sci Rep. 9(878)2019.PubMed/NCBI View Article : Google Scholar | |
|
Rabadi MM, Xavier S, Vasko R, Kaur K, Goligorksy MS and Ratliff BB: High-mobility group box 1 is a novel deacetylation target of Sirtuin1. Kidney Int. 87:95–108. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Hwang JS, Choi HS, Ham SA, Yoo T, Lee WJ, Paek KS and Seo HG: Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia. Sci Rep. 5(15971)2015.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, He L, Tu M, Huang M, Chen Y, Pan D, Peng J and Shen X: The ameliorative effect of terpinen-4-ol on ER stress-induced vascular calcification depends on SIRT1-mediated regulation of PERK acetylation. Pharmacol Res. 170(105629)2021.PubMed/NCBI View Article : Google Scholar | |
|
Sun Z, Zhang L, Yin K, Zang G, Qian Y, Mao X, Li L, Jing Q and Wang Z: SIRT3-and FAK-mediated acetylation-phosphorylation crosstalk of NFATc1 regulates Nε-carboxymethyl-lysine-induced vascular calcification in diabetes mellitus. Atherosclerosis. 377:43–59. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Jaisson S, Pietrement C and Gillery P: Carbamylation-derived products: Bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis. Clin Chem. 57:1499–1505. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Berg AH, Drechsler C, Wenger J, Buccafusca R, Hod T, Kalim S, Ramma W, Parikh SM, Steen H, Friedman DJ, et al: Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Sci Transl Med. 5(175ra29)2013.PubMed/NCBI View Article : Google Scholar | |
|
Mori D, Matsui I, Shimomura A, Hashimoto N, Matsumoto A, Shimada K, Yamaguchi S, Oka T, Kubota K, Yonemoto S, et al: Protein carbamylation exacerbates vascular calcification. Kidney Int. 94:72–90. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Alesutan I, Luong TTD, Schelski N, Masyout J, Hille S, Schneider MP, Graham D, Zickler D, Verheyen N, Estepa M, et al: Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signalling. Cardiovasc Res. 117:930–941. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Goettsch C, Kjolby M and Aikawa E: Sortilin and its multiple roles in cardiovascular and metabolic diseases. Arterioscler Thromb Vasc Biol. 38:19–25. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Jankowski V, Saritas T, Kjolby M, Hermann J, Speer T, Himmelsbach A, Mahr K, Marina Heuschkel A, Schunk SJ, Thirup S, et al: Carbamylated sortilin associates with cardiovascular calcification in patients with chronic kidney disease. Kidney Int. 101:574–584. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Massy ZA and Liabeuf S: Sortilin, carbamylation, and cardiovascular calcification in chronic kidney disease. Kidney Int. 101:456–459. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Lumibao JC, Tremblay JR, Hsu J and Engle DD: Altered glycosylation in pancreatic cancer and beyond. J Exp Med. 219(e20211505)2022.PubMed/NCBI View Article : Google Scholar | |
|
Karunakaran U and Jeoung NH: O-GlcNAc modification: Friend or foe in diabetic cardiovascular disease. Korean Diabetes J. 34:211–219. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Xu TH, Du Y, Sheng Z, Li Y, Qiu X, Tian B and Yao L: OGT-mediated KEAP1 glycosylation accelerates NRF2 degradation leading to high phosphate-induced vascular calcification in chronic kidney disease. Front Physiol. 11(1092)2020.PubMed/NCBI View Article : Google Scholar | |
|
Xu TH, Sheng Z, Li Y, Qiu X, Tian B and Yao L: OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP. Life Sci. 261(118121)2020.PubMed/NCBI View Article : Google Scholar | |
|
Siddals KW, Allen J, Sinha S, Canfield AE, Kalra PA and Gibson JM: Apposite insulin-like growth factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralization. J Biol Chem. 286:16623–16630. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Watson KE, Boström K, Ravindranath R, Lam T, Norton B and Demer LL: TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest. 93:2106–2113. 1994.PubMed/NCBI View Article : Google Scholar | |
|
Kanno Y, Into T, Lowenstein CJ and Matsushita K: Nitric oxide regulates vascular calcification by interfering with TGF-signalling. Cardiovasc Res. 77:221–230. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Sha X, Brunner AM, Purchio AF and Gentry LE: Transforming growth factor beta 1: Importance of glycosylation and acidic proteases for processing and secretion. Mol Endocrinol. 3:1090–1098. 1989.PubMed/NCBI View Article : Google Scholar | |
|
Watanabe S, Misawa M, Matsuzaki T, Sakurai T, Muramatsu T and Sato M: A novel glycosylation signal regulates transforming growth factor beta receptors as evidenced by endo-beta-galactosidase C expression in rodent cells. Glycobiology. 21:482–492. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Wen X, Liu A, Yu C, Wang L, Zhou M, Wang N, Fang M, Wang W and Lin H: Inhibiting post-translational core fucosylation prevents vascular calcification in the model of uremia. Int J Biochem Cell Biol. 79:69–79. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Miyata T, van Ypersele de Strihou C, Kurokawa K and Baynes JW: Alterations in nonenzymatic biochemistry in uremia: Origin and significance of ‘carbonyl stress’ in long-term uremic complications. Kidney Int. 55:389–399. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Rabbani N and Thornalley PJ: Advanced glycation end products in the pathogenesis of chronic kidney disease. Kidney Int. 93:803–813. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Hangai M, Takebe N, Honma H, Sasaki A, Chida A, Nakano R, Togashi H, Nakagawa R, Oda T, Matsui M, et al: Association of advanced glycation end products with coronary artery calcification in japanese subjects with type 2 diabetes as assessed by skin autofluorescence. J Atheroscler Thromb. 23:1178–1187. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Janda K, Krzanowski M, Gajda M, Dumnicka P, Jasek E, Fedak D, Pietrzycka A, Kuźniewski M, Litwin JA and Sułowicz W: Vascular effects of advanced glycation end-products: Content of immunohistochemically detected AGEs in radial artery samples as a predictor for arterial calcification and cardiovascular risk in asymptomatic patients with chronic kidney disease. Dis Markers. 2015(153978)2015.PubMed/NCBI View Article : Google Scholar | |
|
Koike S, Yano S, Tanaka S, Sheikh AM, Nagai A and Sugimoto T: Advanced glycation end-products induce apoptosis of vascular smooth muscle cells: A mechanism for vascular calcification. Int J Mol Sci. 17(1567)2016.PubMed/NCBI View Article : Google Scholar | |
|
Wei Q, Ren X, Jiang Y, Jin H, Liu N and Li J: Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress. BMC Cardiovasc Disord. 13(13)2013.PubMed/NCBI View Article : Google Scholar | |
|
Bro S, Flyvbjerg A, Binder CJ, Bang CA, Denner L, Olgaard K and Nielsen LB: A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice. Atherosclerosis. 201:274–280. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Movérare-Skrtic S, Voelkl J, Nilsson KH, Nethander M, Luong TTD, Alesutan I, Li L, Wu J, Horkeby K, Lagerquist MK, et al: B4GALNT3 regulates glycosylation of sclerostin and bone mass. EBioMedicine. 91(104546)2023.PubMed/NCBI View Article : Google Scholar | |
|
Tong YT, Gao GJ, Chang H, Wu XW and Li MT: Development and economic assessment of machine learning models to predict glycosylated hemoglobin in type 2 diabetes. Front Pharmacol. 14(1216182)2023.PubMed/NCBI View Article : Google Scholar | |
|
Hoek AG, Zwakenberg SR, Elders PJM, de Jong PA, Spiering W, Bartstra JW, Doesburg T, van der Heijden AA, van der Schouw YT and Beulens JWJ: SMART Study Group. An elevated ankle-brachial index is not a valid proxy for peripheral medial arterial calcification. Atherosclerosis. 323:13–19. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ferraresi R, Ucci A, Pizzuto A, Losurdo F, Caminiti M, Minnella D, Casini A, Clerici G, Montero-Baker M and Mills J: A novel scoring system for small artery disease and medial arterial calcification is strongly associated with major adverse limb events in patients with chronic limb-threatening ischemia. J Endovasc Ther. 28:194–207. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Lanzer P, Hannan FM, Lanzer JD, Janzen J, Raggi P, Furniss D, Schuchardt M, Thakker R, Fok PW, Saez-Rodriguez J, et al: Medial arterial calcification: JACC state-of-the-art review. J Am Coll Cardiol. 78:1145–1165. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ruf N, Uhlenberg B, Terkeltaub R, Nürnberg P and Rutsch F: The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI). Hum Mutat. 25(98)2005.PubMed/NCBI View Article : Google Scholar | |
|
Nitschke Y, Baujat G, Botschen U, Wittkampf T, du Moulin M, Stella J, Le Merrer M, Guest G, Lambot K, Tazarourte-Pinturier MF, et al: Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet. 90:25–39. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Harja E, Bu DX, Hudson BI, Chang JS, Shen X, Hallam K, Kalea AZ, Lu Y, Rosario RH, Oruganti S, et al: Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest. 118:183–194. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Lin Y and Sun Z: Klotho deficiency-induced arterial calcification involves osteoblastic transition of VSMCs and activation of BMP signaling. J Cell Physiol. 237:720–729. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Pan W, Jie W and Huang H: Vascular calcification: Molecular mechanisms and therapeutic interventions. MedComm (2020). 4(e200)2023.PubMed/NCBI View Article : Google Scholar | |
|
UniProt Consortium: UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Res. 49 (D1):D480–D489. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Luo S, Kong C, Zhao S, Tang X, Wang Y, Zhou X, Li R, Liu X, Tang X, Sun S, et al: Endothelial HDAC1-ZEB2-NuRD complex drives aortic aneurysm and dissection through regulation of protein S-sulfhydration. Circulation. 147:1382–1403. 2023.PubMed/NCBI View Article : Google Scholar |
